SG10202102365XA - Composition for suppressing or improving eye fatigue - Google Patents
Composition for suppressing or improving eye fatigueInfo
- Publication number
- SG10202102365XA SG10202102365XA SG10202102365XA SG10202102365XA SG10202102365XA SG 10202102365X A SG10202102365X A SG 10202102365XA SG 10202102365X A SG10202102365X A SG 10202102365XA SG 10202102365X A SG10202102365X A SG 10202102365XA SG 10202102365X A SG10202102365X A SG 10202102365XA
- Authority
- SG
- Singapore
- Prior art keywords
- suppressing
- composition
- eye fatigue
- improving eye
- improving
- Prior art date
Links
- 208000003464 asthenopia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Ophthalmology & Optometry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016177039 | 2016-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10202102365XA true SG10202102365XA (en) | 2021-04-29 |
Family
ID=61562181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202102365XA SG10202102365XA (en) | 2016-09-09 | 2017-09-08 | Composition for suppressing or improving eye fatigue |
Country Status (6)
Country | Link |
---|---|
US (3) | US11389494B2 (en) |
EP (1) | EP3511011A4 (en) |
JP (2) | JP6640803B2 (en) |
CA (1) | CA3036197C (en) |
SG (1) | SG10202102365XA (en) |
WO (1) | WO2018047930A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7049397B2 (en) * | 2020-06-10 | 2022-04-06 | キリンホールディングス株式会社 | Composition for suppressing or improving depression |
WO2022255553A1 (en) * | 2021-06-03 | 2022-12-08 | 주식회사 엠디헬스케어 | Composition for preventing or treating eye diseases comprising extracellular vesicles derived from lactobacillus paracasei |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE421256T1 (en) | 2003-03-13 | 2009-02-15 | Kirin Holdings Kk | PROBIOTIC COMPOSITION |
US20090312438A1 (en) | 2008-06-13 | 2009-12-17 | Bernstein Paul S | Compositions and Methods for Attenuating the Formation of A2E in the Retinal Pigment Epithelium |
NZ613335A (en) * | 2010-12-28 | 2015-05-29 | Kirin Holdings Kk | Agent for inducing interferon production containing lactic acid bacteria |
CN105025909B (en) * | 2013-02-27 | 2020-05-19 | 株式会社明治 | Stress-reducing agent |
CN108135956B (en) | 2015-07-13 | 2021-06-08 | 东北泰克诺亚奇股份有限公司 | Composition for protecting optic nerve |
IT201600081929A1 (en) | 2016-08-03 | 2018-02-03 | St Europeo Di Oncologia S R L | USE OF THE LACTOBACILLUS PARACASEI SURNATANT IN THE TREATMENT OF CONJUNCTIVITY, IN PARTICULAR OF THE VERNAL CHERATOCONGIUNTIVITE |
-
2017
- 2017-09-08 SG SG10202102365XA patent/SG10202102365XA/en unknown
- 2017-09-08 EP EP17848868.0A patent/EP3511011A4/en active Pending
- 2017-09-08 JP JP2017172620A patent/JP6640803B2/en active Active
- 2017-09-08 US US16/331,849 patent/US11389494B2/en active Active
- 2017-09-08 CA CA3036197A patent/CA3036197C/en active Active
- 2017-09-08 WO PCT/JP2017/032398 patent/WO2018047930A1/en unknown
-
2019
- 2019-12-26 JP JP2019236692A patent/JP6975769B2/en active Active
-
2022
- 2022-06-13 US US17/838,698 patent/US11890309B2/en active Active
-
2023
- 2023-12-21 US US18/392,708 patent/US20240180979A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220323516A1 (en) | 2022-10-13 |
JP2020063297A (en) | 2020-04-23 |
JP2018043986A (en) | 2018-03-22 |
US20190374587A1 (en) | 2019-12-12 |
JP6640803B2 (en) | 2020-02-05 |
JP6975769B2 (en) | 2021-12-01 |
CA3036197A1 (en) | 2018-03-15 |
EP3511011A4 (en) | 2020-03-04 |
US11890309B2 (en) | 2024-02-06 |
EP3511011A1 (en) | 2019-07-17 |
WO2018047930A1 (en) | 2018-03-15 |
CA3036197C (en) | 2023-02-28 |
US20240180979A1 (en) | 2024-06-06 |
US11389494B2 (en) | 2022-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1253915A1 (en) | Composition for surface modification | |
IL249643A0 (en) | Ophthalmic composition | |
LT3426226T (en) | Ophthalmologic composition | |
PL3373973T3 (en) | Ocular compositions | |
HUE059639T2 (en) | Ophthalmic suspension composition | |
PL3081263T3 (en) | Compositions and tools for treating glaucoma | |
PL3273947T3 (en) | Composition for ocular health | |
PL3145511T3 (en) | Composition for treating the eye | |
SG11201707117SA (en) | Ophthalmic composition | |
GB201619525D0 (en) | Ophthalmic composition | |
HK1254371A1 (en) | Viscoelastic composition | |
SG10202102365XA (en) | Composition for suppressing or improving eye fatigue | |
HK1247088A1 (en) | Composition for improving brain function | |
SG11201706794XA (en) | Fatigue improvement agent | |
HUE062406T2 (en) | Compositions for treating ophthalmic conditions | |
PL3446682T3 (en) | Ophthalmic composition | |
ZA201703701B (en) | Ophthalmic composition | |
SI3303486T1 (en) | Surface treatment composition | |
PT3470059T (en) | Ophthalmic suspension composition |